- Home
- BTSG vs PCVX Comparison
BTSG vs PCVX Comparison
Compare BTSG & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTSG
- PCVX
- Stock Information
- Founded
- BTSG 1974
- PCVX 2013
- Country
- BTSG United States
- PCVX United States
- Employees
- BTSG N/A
- PCVX N/A
- Industry
- BTSG
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- BTSG
- PCVX Health Care
- Exchange
- BTSG NYSE
- PCVX Nasdaq
- Market Cap
- BTSG 4.1B
- PCVX 4.4B
- IPO Year
- BTSG 2024
- PCVX 2020
- Fundamental
- Price
- BTSG $20.31
- PCVX $35.76
- Analyst Decision
- BTSG Strong Buy
- PCVX Strong Buy
- Analyst Count
- BTSG 9
- PCVX 10
- Target Price
- BTSG $23.50
- PCVX $136.50
- AVG Volume (30 Days)
- BTSG 2.9M
- PCVX 1.5M
- Earning Date
- BTSG 08-01-2025
- PCVX 08-05-2025
- Dividend Yield
- BTSG N/A
- PCVX N/A
- EPS Growth
- BTSG N/A
- PCVX N/A
- EPS
- BTSG 0.29
- PCVX N/A
- Revenue
- BTSG $11,858,835,000.00
- PCVX N/A
- Revenue This Year
- BTSG $11.55
- PCVX N/A
- Revenue Next Year
- BTSG $12.14
- PCVX N/A
- P/E Ratio
- BTSG $86.20
- PCVX N/A
- Revenue Growth
- BTSG 30.55
- PCVX N/A
- 52 Week Low
- BTSG $10.15
- PCVX $27.66
- 52 Week High
- BTSG $25.57
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- BTSG 33.01
- PCVX 57.77
- Support Level
- BTSG $21.36
- PCVX $31.79
- Resistance Level
- BTSG $22.40
- PCVX $36.89
- Average True Range (ATR)
- BTSG 0.71
- PCVX 1.51
- MACD
- BTSG -0.27
- PCVX 0.37
- Stochastic Oscillator
- BTSG 1.84
- PCVX 77.65
About BTSG BRIGHTSPRING HEALTH SERVICES INC
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.